Replimune - 48 Year Dividend History | REPL

Historical dividend payout and yield for Replimune (REPL) since 1971. The current TTM dividend payout for Replimune (REPL) as of July 19, 2019 is $0.00. The current dividend yield for Replimune as of July 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.383B $0.000B
Replimune Group, Inc. is a clinical-stage biotechnology company. It discovers, develops and commercializes oncolytic immunotherapy for the treatment of cancer diseases. The company's product pipeline consists of RP1, RP2 & RP3 which are in clinical stage. Replimune Group, Inc. is based in MA, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.806B 12.30
Gilead Sciences (GILD) United States $82.919B 10.07
CSL (CSLLY) Australia $35.794B 0.00
Bio-Techne Corp (TECH) United States $7.933B 54.13